Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

NCT03587701 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Inner Ear Disease
Meniere's Disease

Interventions

DRUG: Anakinra 100Mg/0.67Ml Inj Syringe (Period 1)
DRUG: Placebo injection (Period 1)
DRUG: Anakinra 100Mg/0.67Ml Inj Syringe (Period 2)
DRUG: Placebo injection (Period 2)

Sponsor

Northwell Health

Collaborators

[object Object]